The Female Reproductive Tract Microbiome-Implications for Gynecologic Cancers and Personalized Medicine
- PMID: 34208337
- PMCID: PMC8231212
- DOI: 10.3390/jpm11060546
The Female Reproductive Tract Microbiome-Implications for Gynecologic Cancers and Personalized Medicine
Abstract
The microbial colonization of the lower female reproductive tract has been extensively studied over the past few decades. In contrast, the upper female reproductive tract including the uterine cavity and peritoneum where the ovaries and fallopian tubes reside were traditionally assumed to be sterile under non-pathologic conditions. However, recent studies applying next-generation sequencing of the bacterial 16S ribosomal RNA gene have provided convincing evidence for the existence of an upper female reproductive tract microbiome. While the vaginal microbiome and its importance for reproductive health outcomes has been extensively studied, the microbiome of the upper female reproductive tract and its relevance for gynecologic cancers has been less studied and will be the focus of this article. This targeted review summarizes the pertinent literature on the female reproductive tract microbiome in gynecologic malignancies and its anticipated role in future research and clinical applications in personalized medicine.
Keywords: endometrial cancer; female reproductive tract microbiome; gynecologic cancer; ovarian cancer; upper reproductive tract microbiome; uterine microbiome; vaginal microbiome.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Potential contribution of the uterine microbiome in the development of endometrial cancer.Genome Med. 2016 Nov 25;8(1):122. doi: 10.1186/s13073-016-0368-y. Genome Med. 2016. PMID: 27884207 Free PMC article.
-
An evaluation of the microbiota of the upper reproductive tract of women with and without epithelial ovarian cancer.Gynecol Oncol Rep. 2022 Jun 10;42:101017. doi: 10.1016/j.gore.2022.101017. eCollection 2022 Aug. Gynecol Oncol Rep. 2022. PMID: 35754560 Free PMC article.
-
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.Curr Oncol Rep. 2021 Jun 14;23(8):92. doi: 10.1007/s11912-021-01079-x. Curr Oncol Rep. 2021. PMID: 34125319 Review.
-
Metagenomic analysis of the microbiome of the upper reproductive tract: combating ovarian cancer through predictive, preventive, and personalized medicine.EPMA J. 2022 Jun 23;13(3):487-498. doi: 10.1007/s13167-022-00286-1. eCollection 2022 Sep. EPMA J. 2022. PMID: 35762010 Free PMC article.
-
The Female Reproductive Tract Microbiome and Cancerogenesis: A Review Story of Bacteria, Hormones, and Disease.Diagnostics (Basel). 2023 Feb 24;13(5):877. doi: 10.3390/diagnostics13050877. Diagnostics (Basel). 2023. PMID: 36900020 Free PMC article. Review.
Cited by
-
Can probiotics enhance fertility outcome? Capacity of probiotics as a single intervention to improve the feminine genital tract microbiota in non-symptomatic reproductive-aged women.Front Endocrinol (Lausanne). 2023 Jan 19;13:1081830. doi: 10.3389/fendo.2022.1081830. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743917 Free PMC article. Review.
-
The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments.J Microbiol Biotechnol. 2022 Sep 28;32(9):1086-1097. doi: 10.4014/jmb.2208.08002. Epub 2022 Aug 19. J Microbiol Biotechnol. 2022. PMID: 36116940 Free PMC article. Review.
-
The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer.Int J Mol Sci. 2022 May 20;23(10):5756. doi: 10.3390/ijms23105756. Int J Mol Sci. 2022. PMID: 35628566 Free PMC article. Review.
-
The Use of Probiotics for Management and Improvement of Reproductive Eubiosis and Function.Nutrients. 2022 Feb 21;14(4):902. doi: 10.3390/nu14040902. Nutrients. 2022. PMID: 35215551 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
